Non-Metastatic Castration-Resistant Prostate Cancer
Also known as: Non-mestatatic castrate-resistant prostate cancer / Castration resistant, nonmetastatic Prostate Cancer / Non-metastatic, castration-resistant prostate cancer / Nonmetastatic Castration-Resistant Prostate Cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB11901 | Apalutamide | An androgen receptor inhibitor used to treat non-metastatic castration-resistant and metastatic castration-sensitive prostate cancer. |
DB12941 | Darolutamide | An androgen receptor antagonist used for castration-resistant, non-metastatic prostate cancer and metastatic hormone-sensitive prostate cancer. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB05812 | Abiraterone | 1 | Recruiting | 1 |
DB11901 | Apalutamide | 1 | Recruiting | 1 |
DB01248 | Docetaxel | 1 | Recruiting | 1 |
DB00959 | Methylprednisolone | 1 | Recruiting | 1 |
DB00635 | Prednisone | 1 | Recruiting | 1 |
DB11853 | Relugolix | 1 | Recruiting | 1 |
DB05094 | Enzalutamide | 3 | Active Not Recruiting | 1 |
DB08899 | Enzalutamide | 3 | Active Not Recruiting | 1 |
DB12941 | Darolutamide | 4 | Recruiting | 1 |
DB11901 | Apalutamide | Not Available | Active Not Recruiting | 2 |
DB11901 | Apalutamide | Not Available | Completed | 1 |
DB12941 | Darolutamide | Not Available | Active Not Recruiting | 2 |
DB12941 | Darolutamide | Not Available | Completed | 1 |
DB08899 | Enzalutamide | Not Available | Active Not Recruiting | 2 |
DB08899 | Enzalutamide | Not Available | Completed | 1 |